Back to results
US 2018/0021307 A1Published application
Combination Treatment
OwnerRafal Kaminski, Karine Leclercq +1inventors
InventorsRafal Kaminski, Karine Leclercq, Frank Dressen
Life of this patent
Estimating the term…
Abstract
The present invention relates and the combination of lacosamide and brivaracetam for the preparation of a fixed dose combination that is useful in the treatment of epilepsy, epileptogenesis, seizure disorders and convulsions.
Claims12
A pharmaceutical oral fixed-dose combination comprising;
- a) 5-150 mg brivaracetam
- b) 5-250 mg lacosamide, and
- c) a pharmaceutically acceptable excipient.
The method according to claim 9, wherein a daily dose of less than 250 mg of lacosamide and less than 100 mg brivaracetam is administered.
Dependencies are inferred from the claim text.